PGIM India Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.31%)Nav, as on 30-04-2025

  • Previous Nav

  • Net Change on 30-04-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 15.44 20.01 22.50 1.82 8,080.97
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 20.77 24.16 25.01 1.94 4,914.64
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 20.63 23.83 24.41 1.94 3,610.51
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 14.19 19.75 23.89 1.93 3,018.76
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 16.95 18.40 22.23 1.96 2,667.40

Fund Holdings as on 31-March-2025

  • Sun Pharmaceutical Industries Ltd.

  • Divi's Laboratories Ltd.

  • Max Healthcare Institute Ltd.

  • Dr. Reddy's Laboratories Ltd.

  • Mankind Pharma Ltd.

  • Aster DM Healthcare Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Krishna Inst of Medical Sciences Ltd.

  • Abbott India Ltd.

  • Clearing Corporation of India Ltd.

  • Ajanta Pharma Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Global Health Ltd.

  • ICICI Lombard General Insurance Co. Ltd.

  • Cipla Ltd.

  • PB Fintech Ltd.

  • Jupiter Life Line Hospitals Ltd.

  • Syngene International Ltd.

  • IPCA Laboratories Ltd.

  • Dr. Lal Path Labs Ltd.

  • Navin Fluorine International Ltd.

  • Sagility India Ltd.

  • Rainbow Children's Medicare Ltd.

  • Neuland Laboratories Ltd.

  • Sanofi Consumer Healthcare India Ltd.

  • Sanofi India Ltd.

  • Sai Life Sciences Ltd

  • Zydus Lifesciences Ltd.

  • Orchid Pharma Ltd.

  • Net Receivables / (Payables)

  • Akums Drugs And Pharmaceuticals Ltd.

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Miscellaneous

  • Insurance

  • Fintech

  • Chemicals

View More

Fund Manager

  • Cash

  • Equity

View More

About PGIM India Healthcare Fund

Scheme Analysis

PGIM India Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to PGIM India Mutual Fund. It was launched on 06-Dec-2024 and currently has an AUM of ₹104.18 crore. PGIM India Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index.

The NAV of PGIM India Healthcare Fund ended down ₹-0.03(-0.31%)yesterday to ₹9.53.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The PGIM India Healthcare Fund is managed by Puneet Pal and Anandha Padmanabhan Anjeneyan.

Fund House Contact

4th Floor, C Wing, Laxmi Towers, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051

+91 (22) 61593000
care@pgimindia.com
+91 (22) 61593100